03-31-2022
| INR/share | |
| Price | 335.60 |
| Dividend | 0.00 |
| Earnings | 7.17 |
| Cash-flow | 9.05 |
| Book value | 63.32 |
| Equity | 59.75 |
Biocon is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Biocon is a company from India, and his stocks are publicly traded.
Biocon paid a total dividend of 0 million INR last year, for a market value of 399,028 millions (Market Cap 151,949 millions). Dividend per share of Biocon is 0.00 INR, and his stock market price 335.60 INR.
According to the chart below where dividend yield is displayed, Biocon, has a dividend yield of 0%, amount in contrast with the positive dividend offered by both the market average and companies from India, Health Care industry, and Pharmaceuticals and Biotechnology sector. This lack of dividends of Biocon might harm the evolution of share price if the company is not clearly expanding his business.
In addition, you should compare Biocon dividend yield with other Pharmaceuticals and Biotechnology companies or firms from India.
Biocon Dividend Payout
About the ability of Biocon to maintain his current dividend of INR 0.00 per share, an amount that accounts for 0.00%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Biocon payout on ernings is currently 0.00%, which is lower than the market average and companies in his industry and sector.
The following figure shows payout ratios over earnings and cashflow of Biocon, compared againt world market average, India companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.
Biocon Dividend History
| Year | Yield | INR | Paypout | Shares* |
| Present | 0.00% | 0.00 | 0.00% | 1,189 |
| 2021 | 0.00% | 0.00 | 0.00% | 1,189 |
| 2020 | 0.00% | 0.00 | 0.00% | 1,185 |
| 2019 | 0.17% | 0.50 | 6.35% | 1,183 |
| 2018 | 0.16% | 1.01 | 15.61% | 600 |
*In millions
Biocon Stock performance
Finally, last moth Biocon showed a return of -3.80% compared to a worldwide 1.12% average, and a 1.32% of Health Care firms. Over the last year, the company obtained a -17.90% versus a worldwide performance of a 5.73%. More detailed information can be seen in the following graph for India and Pharmaceuticals and Biotechnology firms.
